The synergy between Univestin® and AmLexin™ combine natural innovation with extensive research to deliver a powerful solution for joint performance. Studies show they work synergistically to reduce pain sensitivity, support recovery from exercise‑induced soreness, and help preserve articular cartilage matrix integrity, including reductions in the key biomarker uCTX‑II.
Both ingredients were developed using Unigen’s PhytoLogix® technology platform—an advanced botanical discovery system analysing over 12,000 plants and more than 300,000 fractions. Screening of more than 1,230 medicinal plants identified the key bioactive compounds responsible for COX and LOX modulation, cartilage protection, and broader joint‑health benefits.
Learn more about the Univestin® and Amlexin™ Synergy by requesting our summary research here.
Produced by Unigen, Inc. and distributed in Europe & South Africa by the LEHVOSS Group.
